FDA Alert: Natalizumab (marketed as Tysabri)
Links shared publicly online about this topic.
- 1,741total visits
FDA Alert: Natalizumab (marketed as Tysabri)
View full resource at drugs.com
Most Recently Shared on September 18, 2009 at 2:16 am By:
FDA Alert - FDA Reports PML Cases in Tysabri (natalizumab) Patients - http://bit.ly/tvthZ
FDA Alert: Tysabri (natalizumab): Update of Healthcare Professional Information
drugs.com — “FDA Alert: Tysabri (natalizumab): Update of Healthcare Professional Information” View full resource at drugs.com
Most Recently Shared on April 23, 2011 at 11:06 pm By:
FDA Alert - Update of Healthcare Professional Information: Tysabri (natalizumab) - http://bit.ly/dV3ExV
FDA Alert: Tysabri (Natalizumab): Update of Healthcare Professional Information
drugs.com — “FDA Alert: Tysabri (Natalizumab): Update of Healthcare Professional Information” View full resource at drugs.com
Most Recently Shared on February 7, 2010 at 10:06 pm By:
FDA Alert - Revisions to Prescribing Information for Tysabri (natalizumab) - http://bit.ly/b2C46Z
Medical News: FDA Adds PML Risk to MS Drug Label - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- A warning of a risk of progressive multifocal leukoencephalopathy has been added to the label for the multiple sclerosis drug natalizumab (Tysabri), the FDA announced.” View full resource at medpagetoday.com
Most Recently Shared on February 5, 2010 at 10:07 pm By:
FDA Adds PML Risk to MS Drug Label WASHINGTON (MedPage Today) -- A warning of a risk of progressive multifocal leukoe.. http://bit.ly/bkEhX3
Information on Natalizumab (marketed as Tysabri)
fda.gov — “Information on Natalizumab (marketed as Tysabri)” View full resource at fda.gov
Most Recently Shared on September 16, 2009 at 7:36 pm By:
Gannett Healthcare Health News
FDA receives reports of PML in patients receiving Tysabri: http://bit.ly/SD3Nr
Advertisement
